Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DocGo Inc. Director's Dealing 2022

Mar 22, 2022

33981_dirs_2022-03-21_339d6950-dfdf-484c-8791-70e3e9d92d79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2022-03-11

Reporting Person: Sugrue Stephen (Chief Compliance Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to Buy $3.25 2031-01-07 Common stock (16129) Direct
Option to Buy $8.80 2031-12-07 Common stock (250) Direct
Option to Buy $3.25 2031-01-07 Common stock (16129) Direct
Option to Buy $8.80 2031-12-07 Common stock (250) Direct
Option to Buy $3.25 2031-01-07 Common stock (16129) Direct
Option to Buy $8.80 2031-12-07 Common stock (250) Direct
Option to Buy $3.25 2031-01-07 Common stock (16129) Direct
Option to Buy $8.80 2031-12-07 Common stock (250) Direct

Footnotes

F1: Mr. Sugrue was granted 64,515 (as converted) options on January 7, 2021, vesting 25% annually over a four-year period.

F2: Mr. Sugrue was granted 1,000 options on December 7, 2021, vesting 25% annually over a four-year period.